The metabolic syndrome and nonfatal ischemic heart disease; a population-based study

International Journal of Cardiology

Volumn 118, Issue 1, 2007, Pages 48-53

  Nabipour, Iraj ^a   Amiri, Mohammad ^a   Imami, Seyed Reza ^a   Jahfari, Seyed Mojtaba ^a   Shafeiae, Ebrahim ^a   Nosrati, Abbas ^a   Iranpour, Dariush ^a   Soltanian, Ali Reza ^a  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Electrocardiogram; Insulin resistance; Ischemic heart disease; Metabolic syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ABDOMINAL FAT; ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; DISEASE ASSOCIATION; DYSLIPIDEMIA; ELECTROCARDIOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; IRAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL;

ADULT; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IRAN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MYOCARDIAL ISCHEMIA; POPULATION SURVEILLANCE; PREVALENCE; QUESTIONNAIRES; RISK FACTORS;

EID: 34047145908     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.06.017     Document Type: Article

References (32)

1. Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27 (2004) 2444-2449
2. Liese A.D., Mayer-Davis E.J., and Haffner S.M. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 20 (1998) 157-172
3. Grundy S. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 105 (2002) 2696-2698
4. Malik S., Wong N.D., Franklin S.S., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
5. Vitarius J.A. The metabolic syndrome and cardiovascular disease. Mt Sinai J med 72 (2005) 257-262
6. Pasqui A.L., Puccetti L., Di Renzo M., et al. Structural and functional abnormality of systemic microvessels in cardiac syndrome X. Nutr Metab Cardiovasc Dis 15 (2005) 56-64
7. Turhan H., Yasar A.S., Erbay A.R., Yetkin E., Sasmaz H., and Sabah I. Impaired coronary collateral vessel development in patients with metabolic syndrome. Coron Artery Dis 16 (2005) 281-285
8. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
9. Ford E.S. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173 (2004) 309-314
10. Hunt K.J., Resendez R.G., Williams K., Haffner S.M., and Stern M.P. San Antonio Heart Study. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110 (2004) 1251-1257
11. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
12. Resnick H.E., Jones K., Ruotolo G., et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 26 (2003) 861-867
13. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino Sr. R.B., and Wilson P.W. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110 (2004) 380-385
14. Mc Neili A.M., Rosamond W., Girman C.J., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 28 (2005) 385-390
15. Lindblad U., Langer R.D., Wingard D.L., Thomas R.G., and Barrett-Connor E.L. Metabolic syndrome and ischemic heart disease in elderly men and women. Am J Epidemiol 153 (2001) 481-489
16. Bonora E., Kiechl S., Willeit J., et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome. Diabetes Care 26 (2003) 1251-1257
17. Cerniauskiene L.R., Reklaitiene R., Luksiene D.I., Domarkiene S., Tamosiunas A., and Margeviciene L. Association of metabolic syndrome with ischemic heart disease among middle-aged Kaunas population. Medicina 41 (2005) 435-441
18. WHO MONICA Project. MONICA manual, 1999 (http://www.ktl.fi/publications/monica/manual/index.htm).
19. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
20. Prineas R.J., Crowe R.S., and Blackburn H. The Minnesota Code manual of electrocardiographic findings (1982), John Wright, Bristol
21. Choudhury S.R., Yoshida Y., Kita Y., and Nozaki A. Association between electrocardiographic ischemic abnormalities and ischemic heart disease risk factors in a Japanese population. J Hum Hypertens 10 (1996) 225-234
22. Sattar N., Gaw A., Scherbakova O., et al. Metabolic syndrome with and without C-reactive protein as a predictor of heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
23. Macfarlane P.W., and Norrie J. Looking for prognostic information in the ST-T segment. Is it really worth it?. J Electrocardiol 37 (2004) 209-213
24. De Bacquer D., De Backer G., Kornitzer M., and Blackburn H. Prognostic value of ECK findings for total, cardiovascular disease, and heart disease death in men and women. Heart 80 (1998) 570-577
25. Sarrf-Zadegan N., Sayed-Tabatabaei F.A., Bashardoost N., et al. The prevalence of coronary artery disease in an urban population in Isfahan, Iran. Acta Cardiol 54 (1999) 257-263
26. De Bacquer D., De Backer G., Kornitzer M., et al. Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women. J Am Coll Cardiol 32 (1998) 680-685
27. Macfarlane P.W. Minnesota coding and the prevalence of ECG abnormalities. Heart 84 (2000) 582-584
28. Cameron A.J., Shaw J.E., and Zimmet P.Z. The metabolic syndrome: prevalence in worldwide population. Endocrinol Metab Clin N Am 33 (2004) 351-375
29. Azizi F., Salehi P., Etemadi A., and Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 61 (2003) 29-37
30. Natali A., and Ferrannini E. Hypertension, insulin resistance, and the metabolic syndrome. Endocrinol Metab Clin N Am 33 (2004) 417-429
31. Wong N.D., Pio J.R., Franklin S.S., L'Italien G.J., Pio J.R., and Williams G.R. Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. Am J Cardiol 91 (2003) 1421-1426
32. Sorrentino M.J. Implications of the metabolic syndrome: the new epidemic. Am J Cardiol 96 4A (2005) 3E-7E